Sign in
8-K

Current Report

MoonLake Immunotherapeutics Filed Acc 0001213900-25-052140

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading ea0245015-8k_moonlake.htm…